Secondaries announced 6.8.2016
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Sarepta Therapeutics, Inc. Symbol: SRPT Price: Last trade $19.44 Description: Re-offer range: $18.10-$18.70 Trade Date: 6/9 Shares: 1.9 million Underwriter(s) Credit[…]